Literature DB >> 22766233

The postsynaptic density protein Abelson interactor protein 1 interacts with the motor protein Kinesin family member 26B in hippocampal neurons.

J Heinrich1, C Proepper, T Schmidt, L Linta, S Liebau, T M Boeckers.   

Abstract

Abelson interactor protein 1 (Abi-1) localizes to postsynaptic densities (PSDs) of excitatory synapses and was shown to be transported from the PSD to the nucleus and back depending upon synaptic activation. We employed a yeast-two-hybrid screen to search for putative transport molecules. We found Kif26B a member of the Kif family of transport proteins that has not been characterized in the central nervous system as a direct interaction partner of Abi-1. We delineated a proline-rich motif within the cargo-binding domain of Kif26B to be responsible for this protein-protein interaction. Kif26B was able to recruit Abi-1 to the microtubule network and we found that the expression of Kif26B is responsible for the localization of Abi-1 to PSDs in maturing neurons. Taken together we report that Abi-1 is a cargo of Kif26B in primary hippocampal neurons, pointing to a role of this transport molecule in the movement of Abi-1 between different cell compartments. Additionally, we provide the first detailed investigation of Kif26B and its cargo molecules in neuronal cells.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766233     DOI: 10.1016/j.neuroscience.2012.06.055

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  De novo variant in KIF26B is associated with pontocerebellar hypoplasia with infantile spinal muscular atrophy.

Authors:  Monica H Wojcik; Kyoko Okada; Sanjay P Prabhu; Dan W Nowakowski; Keri Ramsey; Chris Balak; Sampath Rangasamy; Catherine A Brownstein; Klaus Schmitz-Abe; Julie S Cohen; Ali Fatemi; Jiahai Shi; Ellen P Grant; Vinodh Narayanan; Hsin-Yi Henry Ho; Pankaj B Agrawal
Journal:  Am J Med Genet A       Date:  2018-08-27       Impact factor: 2.802

2.  Placental DNA Methylation Related to Both Infant Toenail Mercury and Adverse Neurobehavioral Outcomes.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Barry Lester; E Andrés Houseman; David A Armstrong; Karl T Kelsey; Carmen J Marsit
Journal:  Environ Health Perspect       Date:  2015-03-06       Impact factor: 9.031

3.  Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.

Authors:  Jingtao Wang; Feifei Cui; Xiao Wang; Yingming Xue; Jian Chen; Yang Yu; Huijun Lu; Meng Zhang; Huamei Tang; Zhihai Peng
Journal:  J Exp Clin Cancer Res       Date:  2015-02-05

4.  Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion.

Authors:  Shudong Gu; Haibin Liang; Donghui Qi; Liyan Mao; Guoxin Mao; Li Qian; Shu Zhang
Journal:  Onco Targets Ther       Date:  2018-05-29       Impact factor: 4.147

5.  Association of a Novel KIF26B Gene Polymorphism with Susceptibility to Schizophrenia and Breast Cancer: A Case-Control Study.

Authors:  Saman Sargazi; Milad Heidari Nia; Shekoufeh Mirinejad; Mahdiyeh Moudi; Mahdiyeh Jafari Shahroudi; Ramin Saravani; Sadegh Valian-Borojeni
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

6.  Kif26b controls endothelial cell polarity through the Dishevelled/Daam1-dependent planar cell polarity-signaling pathway.

Authors:  Aude Guillabert-Gourgues; Beatrice Jaspard-Vinassa; Marie-Lise Bats; Raj N Sewduth; Nathalie Franzl; Claire Peghaire; Sylvie Jeanningros; Catherine Moreau; Etienne Roux; Frederic Larrieu-Lahargue; Pascale Dufourcq; Thierry Couffinhal; Cecile Duplàa
Journal:  Mol Biol Cell       Date:  2016-01-20       Impact factor: 4.138

7.  miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway.

Authors:  Hua Li; Shen Shen; Xiaolong Chen; Zhigang Ren; Zhiqin Li; Zujiang Yu
Journal:  Cancer Cell Int       Date:  2019-07-31       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.